nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TUBB—Docetaxel—pancreatic cancer	0.305	0.382	CbGbCtD
Podofilox—TOP2A—Epirubicin—pancreatic cancer	0.228	0.285	CbGbCtD
Podofilox—TOP2A—Doxorubicin—pancreatic cancer	0.121	0.152	CbGbCtD
Podofilox—CYP2C19—Tamoxifen—pancreatic cancer	0.0478	0.0599	CbGbCtD
Podofilox—CYP3A4—Tamoxifen—pancreatic cancer	0.0231	0.029	CbGbCtD
Podofilox—CYP3A4—Erlotinib—pancreatic cancer	0.0196	0.0246	CbGbCtD
Podofilox—CYP3A4—Irinotecan—pancreatic cancer	0.0177	0.0222	CbGbCtD
Podofilox—CYP3A4—Docetaxel—pancreatic cancer	0.013	0.0163	CbGbCtD
Podofilox—CYP3A4—Sunitinib—pancreatic cancer	0.0129	0.0162	CbGbCtD
Podofilox—CYP3A4—Doxorubicin—pancreatic cancer	0.00969	0.0122	CbGbCtD
Podofilox—Scab—Fluorouracil—pancreatic cancer	0.00448	0.0305	CcSEcCtD
Podofilox—TUBA4A—Gefitinib—Erlotinib—pancreatic cancer	0.00373	0.443	CbGdCrCtD
Podofilox—Application site pain—Fluorouracil—pancreatic cancer	0.00324	0.0221	CcSEcCtD
Podofilox—Redness—Tamoxifen—pancreatic cancer	0.00312	0.0213	CcSEcCtD
Podofilox—Blister—Tamoxifen—pancreatic cancer	0.00292	0.0199	CcSEcCtD
Podofilox—Blister—Erlotinib—pancreatic cancer	0.00289	0.0197	CcSEcCtD
Podofilox—Blister—Sunitinib—pancreatic cancer	0.0025	0.0171	CcSEcCtD
Podofilox—Tenderness—Tamoxifen—pancreatic cancer	0.00241	0.0165	CcSEcCtD
Podofilox—Tenderness—Erlotinib—pancreatic cancer	0.00239	0.0163	CcSEcCtD
Podofilox—Inflammation—Tamoxifen—pancreatic cancer	0.00217	0.0148	CcSEcCtD
Podofilox—Inflammation—Erlotinib—pancreatic cancer	0.00215	0.0146	CcSEcCtD
Podofilox—Skin exfoliation—Tamoxifen—pancreatic cancer	0.00201	0.0137	CcSEcCtD
Podofilox—Skin discolouration—Sunitinib—pancreatic cancer	0.002	0.0136	CcSEcCtD
Podofilox—Skin exfoliation—Erlotinib—pancreatic cancer	0.00199	0.0136	CcSEcCtD
Podofilox—Blister—Fluorouracil—pancreatic cancer	0.00197	0.0135	CcSEcCtD
Podofilox—Tingling sensation—Fluorouracil—pancreatic cancer	0.00177	0.0121	CcSEcCtD
Podofilox—Stinging—Fluorouracil—pancreatic cancer	0.00176	0.012	CcSEcCtD
Podofilox—Swelling—Tamoxifen—pancreatic cancer	0.00173	0.0118	CcSEcCtD
Podofilox—Skin exfoliation—Sunitinib—pancreatic cancer	0.00172	0.0117	CcSEcCtD
Podofilox—Tenderness—Gemcitabine—pancreatic cancer	0.00166	0.0113	CcSEcCtD
Podofilox—Tenderness—Fluorouracil—pancreatic cancer	0.00163	0.0111	CcSEcCtD
Podofilox—Dermatitis bullous—Tamoxifen—pancreatic cancer	0.0016	0.0109	CcSEcCtD
Podofilox—Dermatitis bullous—Erlotinib—pancreatic cancer	0.00158	0.0108	CcSEcCtD
Podofilox—Ulcer—Irinotecan—pancreatic cancer	0.00157	0.0107	CcSEcCtD
Podofilox—Ulcer—Gemcitabine—pancreatic cancer	0.00153	0.0104	CcSEcCtD
Podofilox—Redness—Docetaxel—pancreatic cancer	0.00152	0.0104	CcSEcCtD
Podofilox—Ulcer—Fluorouracil—pancreatic cancer	0.0015	0.0103	CcSEcCtD
Podofilox—Inflammation—Fluorouracil—pancreatic cancer	0.00147	0.01	CcSEcCtD
Podofilox—Dry skin—Erlotinib—pancreatic cancer	0.00139	0.00945	CcSEcCtD
Podofilox—Skin exfoliation—Gemcitabine—pancreatic cancer	0.00138	0.00942	CcSEcCtD
Podofilox—Dermatitis bullous—Sunitinib—pancreatic cancer	0.00137	0.00934	CcSEcCtD
Podofilox—Dry skin—Sunitinib—pancreatic cancer	0.0012	0.00818	CcSEcCtD
Podofilox—Swelling—Fluorouracil—pancreatic cancer	0.00117	0.00798	CcSEcCtD
Podofilox—Dermatitis bullous—Gemcitabine—pancreatic cancer	0.0011	0.0075	CcSEcCtD
Podofilox—Dermatitis bullous—Fluorouracil—pancreatic cancer	0.00108	0.00737	CcSEcCtD
Podofilox—Haemoglobin—Tamoxifen—pancreatic cancer	0.00106	0.00725	CcSEcCtD
Podofilox—Inflammation—Docetaxel—pancreatic cancer	0.00106	0.00722	CcSEcCtD
Podofilox—Haemorrhage—Tamoxifen—pancreatic cancer	0.00106	0.00721	CcSEcCtD
Podofilox—Haemoglobin—Erlotinib—pancreatic cancer	0.00105	0.00717	CcSEcCtD
Podofilox—Haemorrhage—Erlotinib—pancreatic cancer	0.00105	0.00714	CcSEcCtD
Podofilox—Redness—Epirubicin—pancreatic cancer	0.00103	0.007	CcSEcCtD
Podofilox—Skin exfoliation—Docetaxel—pancreatic cancer	0.000981	0.00669	CcSEcCtD
Podofilox—TOP2A—Topotecan—Irinotecan—pancreatic cancer	0.000963	0.114	CbGdCrCtD
Podofilox—Blister—Epirubicin—pancreatic cancer	0.000961	0.00655	CcSEcCtD
Podofilox—Redness—Doxorubicin—pancreatic cancer	0.00095	0.00648	CcSEcCtD
Podofilox—Dry skin—Fluorouracil—pancreatic cancer	0.000947	0.00646	CcSEcCtD
Podofilox—Erythema—Tamoxifen—pancreatic cancer	0.000921	0.00628	CcSEcCtD
Podofilox—Erythema—Erlotinib—pancreatic cancer	0.000911	0.00621	CcSEcCtD
Podofilox—Haemoglobin—Sunitinib—pancreatic cancer	0.000911	0.00621	CcSEcCtD
Podofilox—Haemorrhage—Sunitinib—pancreatic cancer	0.000906	0.00618	CcSEcCtD
Podofilox—Skin ulcer—Epirubicin—pancreatic cancer	0.00089	0.00607	CcSEcCtD
Podofilox—Blister—Doxorubicin—pancreatic cancer	0.000889	0.00606	CcSEcCtD
Podofilox—Stinging—Epirubicin—pancreatic cancer	0.000855	0.00583	CcSEcCtD
Podofilox—Swelling—Docetaxel—pancreatic cancer	0.000845	0.00576	CcSEcCtD
Podofilox—Skin ulcer—Doxorubicin—pancreatic cancer	0.000823	0.00561	CcSEcCtD
Podofilox—Immune system disorder—Sunitinib—pancreatic cancer	0.000818	0.00558	CcSEcCtD
Podofilox—Stinging—Doxorubicin—pancreatic cancer	0.000791	0.0054	CcSEcCtD
Podofilox—Erythema—Sunitinib—pancreatic cancer	0.000789	0.00538	CcSEcCtD
Podofilox—Dermatitis bullous—Docetaxel—pancreatic cancer	0.00078	0.00532	CcSEcCtD
Podofilox—Haematuria—Gemcitabine—pancreatic cancer	0.000772	0.00526	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00077	0.00525	CcSEcCtD
Podofilox—Skin discolouration—Epirubicin—pancreatic cancer	0.000767	0.00523	CcSEcCtD
Podofilox—Oedema—Tamoxifen—pancreatic cancer	0.000751	0.00512	CcSEcCtD
Podofilox—Haemoglobin—Irinotecan—pancreatic cancer	0.00075	0.00511	CcSEcCtD
Podofilox—Haemorrhage—Irinotecan—pancreatic cancer	0.000746	0.00509	CcSEcCtD
Podofilox—Oedema—Erlotinib—pancreatic cancer	0.000743	0.00507	CcSEcCtD
Podofilox—Ulcer—Epirubicin—pancreatic cancer	0.000733	0.00499	CcSEcCtD
Podofilox—Haemoglobin—Gemcitabine—pancreatic cancer	0.000731	0.00498	CcSEcCtD
Podofilox—Haemorrhage—Gemcitabine—pancreatic cancer	0.000727	0.00496	CcSEcCtD
Podofilox—Skin disorder—Erlotinib—pancreatic cancer	0.000722	0.00492	CcSEcCtD
Podofilox—Haemoglobin—Fluorouracil—pancreatic cancer	0.000718	0.0049	CcSEcCtD
Podofilox—Haemorrhage—Fluorouracil—pancreatic cancer	0.000715	0.00487	CcSEcCtD
Podofilox—Inflammation—Epirubicin—pancreatic cancer	0.000714	0.00487	CcSEcCtD
Podofilox—Skin discolouration—Doxorubicin—pancreatic cancer	0.00071	0.00484	CcSEcCtD
Podofilox—Dry skin—Docetaxel—pancreatic cancer	0.000683	0.00466	CcSEcCtD
Podofilox—Insomnia—Tamoxifen—pancreatic cancer	0.00068	0.00463	CcSEcCtD
Podofilox—Ulcer—Doxorubicin—pancreatic cancer	0.000678	0.00462	CcSEcCtD
Podofilox—TOP2A—Paclitaxel—Docetaxel—pancreatic cancer	0.000676	0.0803	CbGdCrCtD
Podofilox—Paraesthesia—Tamoxifen—pancreatic cancer	0.000675	0.0046	CcSEcCtD
Podofilox—Immune system disorder—Irinotecan—pancreatic cancer	0.000674	0.0046	CcSEcCtD
Podofilox—Insomnia—Erlotinib—pancreatic cancer	0.000672	0.00459	CcSEcCtD
Podofilox—TUBB—Azacitidine—Gemcitabine—pancreatic cancer	0.000669	0.0795	CbGdCrCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000667	0.00455	CcSEcCtD
Podofilox—Skin exfoliation—Epirubicin—pancreatic cancer	0.000661	0.00451	CcSEcCtD
Podofilox—Inflammation—Doxorubicin—pancreatic cancer	0.000661	0.00451	CcSEcCtD
Podofilox—Immune system disorder—Gemcitabine—pancreatic cancer	0.000657	0.00448	CcSEcCtD
Podofilox—TOP2A—Gefitinib—Erlotinib—pancreatic cancer	0.000648	0.0771	CbGdCrCtD
Podofilox—Oedema—Sunitinib—pancreatic cancer	0.000644	0.00439	CcSEcCtD
Podofilox—Pain—Tamoxifen—pancreatic cancer	0.000643	0.00438	CcSEcCtD
Podofilox—Pain—Erlotinib—pancreatic cancer	0.000636	0.00434	CcSEcCtD
Podofilox—Erythema—Gemcitabine—pancreatic cancer	0.000633	0.00431	CcSEcCtD
Podofilox—Skin disorder—Sunitinib—pancreatic cancer	0.000625	0.00426	CcSEcCtD
Podofilox—Erythema—Fluorouracil—pancreatic cancer	0.000622	0.00424	CcSEcCtD
Podofilox—Skin exfoliation—Doxorubicin—pancreatic cancer	0.000612	0.00417	CcSEcCtD
Podofilox—Etoposide—PTGS2—pancreatic cancer	0.0006	1	CrCbGaD
Podofilox—Insomnia—Sunitinib—pancreatic cancer	0.000582	0.00397	CcSEcCtD
Podofilox—Paraesthesia—Sunitinib—pancreatic cancer	0.000578	0.00394	CcSEcCtD
Podofilox—Pain—Sunitinib—pancreatic cancer	0.00055	0.00375	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000535	0.00365	CcSEcCtD
Podofilox—Pruritus—Tamoxifen—pancreatic cancer	0.000532	0.00363	CcSEcCtD
Podofilox—Oedema—Irinotecan—pancreatic cancer	0.00053	0.00361	CcSEcCtD
Podofilox—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000526	0.00359	CcSEcCtD
Podofilox—Pruritus—Erlotinib—pancreatic cancer	0.000526	0.00359	CcSEcCtD
Podofilox—Haemoglobin—Docetaxel—pancreatic cancer	0.000518	0.00354	CcSEcCtD
Podofilox—Oedema—Gemcitabine—pancreatic cancer	0.000516	0.00352	CcSEcCtD
Podofilox—Haemorrhage—Docetaxel—pancreatic cancer	0.000516	0.00352	CcSEcCtD
Podofilox—Oedema—Fluorouracil—pancreatic cancer	0.000508	0.00346	CcSEcCtD
Podofilox—Skin disorder—Gemcitabine—pancreatic cancer	0.000502	0.00342	CcSEcCtD
Podofilox—Dizziness—Tamoxifen—pancreatic cancer	0.000497	0.00339	CcSEcCtD
Podofilox—Dizziness—Erlotinib—pancreatic cancer	0.000492	0.00335	CcSEcCtD
Podofilox—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000487	0.00332	CcSEcCtD
Podofilox—Insomnia—Irinotecan—pancreatic cancer	0.00048	0.00327	CcSEcCtD
Podofilox—Vomiting—Tamoxifen—pancreatic cancer	0.000478	0.00326	CcSEcCtD
Podofilox—Paraesthesia—Irinotecan—pancreatic cancer	0.000476	0.00325	CcSEcCtD
Podofilox—Rash—Tamoxifen—pancreatic cancer	0.000474	0.00323	CcSEcCtD
Podofilox—Dermatitis—Tamoxifen—pancreatic cancer	0.000473	0.00323	CcSEcCtD
Podofilox—Vomiting—Erlotinib—pancreatic cancer	0.000473	0.00322	CcSEcCtD
Podofilox—Headache—Tamoxifen—pancreatic cancer	0.000471	0.00321	CcSEcCtD
Podofilox—Rash—Erlotinib—pancreatic cancer	0.000469	0.0032	CcSEcCtD
Podofilox—Dermatitis—Erlotinib—pancreatic cancer	0.000468	0.00319	CcSEcCtD
Podofilox—Insomnia—Gemcitabine—pancreatic cancer	0.000467	0.00318	CcSEcCtD
Podofilox—Immune system disorder—Docetaxel—pancreatic cancer	0.000466	0.00318	CcSEcCtD
Podofilox—Headache—Erlotinib—pancreatic cancer	0.000466	0.00318	CcSEcCtD
Podofilox—Paraesthesia—Gemcitabine—pancreatic cancer	0.000464	0.00316	CcSEcCtD
Podofilox—Dry skin—Epirubicin—pancreatic cancer	0.000461	0.00314	CcSEcCtD
Podofilox—Insomnia—Fluorouracil—pancreatic cancer	0.000459	0.00313	CcSEcCtD
Podofilox—Paraesthesia—Fluorouracil—pancreatic cancer	0.000456	0.00311	CcSEcCtD
Podofilox—Pruritus—Sunitinib—pancreatic cancer	0.000455	0.0031	CcSEcCtD
Podofilox—Pain—Irinotecan—pancreatic cancer	0.000453	0.00309	CcSEcCtD
Podofilox—Erythema—Docetaxel—pancreatic cancer	0.000449	0.00306	CcSEcCtD
Podofilox—Pain—Gemcitabine—pancreatic cancer	0.000442	0.00301	CcSEcCtD
Podofilox—Pain—Fluorouracil—pancreatic cancer	0.000434	0.00296	CcSEcCtD
Podofilox—Dry skin—Doxorubicin—pancreatic cancer	0.000427	0.00291	CcSEcCtD
Podofilox—Dizziness—Sunitinib—pancreatic cancer	0.000426	0.0029	CcSEcCtD
Podofilox—Vomiting—Sunitinib—pancreatic cancer	0.000409	0.00279	CcSEcCtD
Podofilox—Rash—Sunitinib—pancreatic cancer	0.000406	0.00277	CcSEcCtD
Podofilox—Dermatitis—Sunitinib—pancreatic cancer	0.000405	0.00276	CcSEcCtD
Podofilox—Headache—Sunitinib—pancreatic cancer	0.000403	0.00275	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00038	0.00259	CcSEcCtD
Podofilox—Haematuria—Epirubicin—pancreatic cancer	0.00037	0.00252	CcSEcCtD
Podofilox—Oedema—Docetaxel—pancreatic cancer	0.000366	0.0025	CcSEcCtD
Podofilox—Pruritus—Gemcitabine—pancreatic cancer	0.000365	0.00249	CcSEcCtD
Podofilox—Pruritus—Fluorouracil—pancreatic cancer	0.000359	0.00245	CcSEcCtD
Podofilox—Skin disorder—Docetaxel—pancreatic cancer	0.000356	0.00243	CcSEcCtD
Podofilox—Dizziness—Irinotecan—pancreatic cancer	0.000351	0.00239	CcSEcCtD
Podofilox—Haemoglobin—Epirubicin—pancreatic cancer	0.00035	0.00238	CcSEcCtD
Podofilox—Haemorrhage—Epirubicin—pancreatic cancer	0.000348	0.00237	CcSEcCtD
Podofilox—Haematuria—Doxorubicin—pancreatic cancer	0.000342	0.00233	CcSEcCtD
Podofilox—Vomiting—Irinotecan—pancreatic cancer	0.000337	0.0023	CcSEcCtD
Podofilox—Dizziness—Fluorouracil—pancreatic cancer	0.000336	0.00229	CcSEcCtD
Podofilox—Rash—Irinotecan—pancreatic cancer	0.000334	0.00228	CcSEcCtD
Podofilox—Dermatitis—Irinotecan—pancreatic cancer	0.000334	0.00228	CcSEcCtD
Podofilox—Headache—Irinotecan—pancreatic cancer	0.000332	0.00226	CcSEcCtD
Podofilox—Insomnia—Docetaxel—pancreatic cancer	0.000331	0.00226	CcSEcCtD
Podofilox—Paraesthesia—Docetaxel—pancreatic cancer	0.000329	0.00224	CcSEcCtD
Podofilox—Vomiting—Gemcitabine—pancreatic cancer	0.000328	0.00224	CcSEcCtD
Podofilox—Rash—Gemcitabine—pancreatic cancer	0.000326	0.00222	CcSEcCtD
Podofilox—Dermatitis—Gemcitabine—pancreatic cancer	0.000325	0.00222	CcSEcCtD
Podofilox—Haemoglobin—Doxorubicin—pancreatic cancer	0.000324	0.00221	CcSEcCtD
Podofilox—Headache—Gemcitabine—pancreatic cancer	0.000324	0.00221	CcSEcCtD
Podofilox—Vomiting—Fluorouracil—pancreatic cancer	0.000323	0.0022	CcSEcCtD
Podofilox—Haemorrhage—Doxorubicin—pancreatic cancer	0.000322	0.0022	CcSEcCtD
Podofilox—Rash—Fluorouracil—pancreatic cancer	0.00032	0.00218	CcSEcCtD
Podofilox—Dermatitis—Fluorouracil—pancreatic cancer	0.00032	0.00218	CcSEcCtD
Podofilox—Headache—Fluorouracil—pancreatic cancer	0.000318	0.00217	CcSEcCtD
Podofilox—Immune system disorder—Epirubicin—pancreatic cancer	0.000314	0.00214	CcSEcCtD
Podofilox—Pain—Docetaxel—pancreatic cancer	0.000313	0.00214	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—IFNA5—pancreatic cancer	0.000306	0.00653	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—AHR—pancreatic cancer	0.000306	0.00652	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.000306	0.00652	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.000305	0.0065	CbGpPWpGaD
Podofilox—Erythema—Epirubicin—pancreatic cancer	0.000303	0.00207	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 2—MYC—pancreatic cancer	0.000301	0.00642	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—RBBP8—pancreatic cancer	0.000298	0.00636	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—EGFR—pancreatic cancer	0.000295	0.00628	CbGpPWpGaD
Podofilox—Immune system disorder—Doxorubicin—pancreatic cancer	0.000291	0.00198	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—PPP2R5B—pancreatic cancer	0.000289	0.00616	CbGpPWpGaD
Podofilox—Erythema—Doxorubicin—pancreatic cancer	0.00028	0.00191	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000279	0.00594	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000275	0.00586	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptors—PPARG—pancreatic cancer	0.000275	0.00586	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—PPP2R5B—pancreatic cancer	0.000273	0.00582	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	0.000272	0.0058	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—AHR—pancreatic cancer	0.000266	0.00566	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.00026	0.00553	CbGpPWpGaD
Podofilox—Pruritus—Docetaxel—pancreatic cancer	0.000259	0.00177	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—VEGFA—pancreatic cancer	0.000258	0.0055	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000256	0.00175	CcSEcCtD
Podofilox—TUBA4A—Metabolism of proteins—PCSK1—pancreatic cancer	0.000249	0.0053	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—SMAD4—pancreatic cancer	0.000248	0.00529	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—TP53—pancreatic cancer	0.000247	0.00527	CbGpPWpGaD
Podofilox—Oedema—Epirubicin—pancreatic cancer	0.000247	0.00169	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	0.000246	0.00524	CbGpPWpGaD
Podofilox—TOP2A—Cytarabine—Gemcitabine—pancreatic cancer	0.000244	0.029	CbGdCrCtD
Podofilox—TUBA4A—Cell Cycle—FOXM1—pancreatic cancer	0.000243	0.00518	CbGpPWpGaD
Podofilox—Dizziness—Docetaxel—pancreatic cancer	0.000242	0.00165	CcSEcCtD
Podofilox—NR3C1—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000241	0.00513	CbGpPWpGaD
Podofilox—NR3C1—Circadian Clock—HIF1A—pancreatic cancer	0.000241	0.00513	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000241	0.00513	CbGpPWpGaD
Podofilox—Skin disorder—Epirubicin—pancreatic cancer	0.00024	0.00164	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000237	0.00162	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—TGFB1—pancreatic cancer	0.000237	0.00504	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000237	0.00504	CbGpPWpGaD
Podofilox—Vomiting—Docetaxel—pancreatic cancer	0.000233	0.00159	CcSEcCtD
Podofilox—TUBB—Cell Cycle—PPP2R5B—pancreatic cancer	0.000232	0.00494	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	0.000231	0.00493	CbGpPWpGaD
Podofilox—Rash—Docetaxel—pancreatic cancer	0.000231	0.00158	CcSEcCtD
Podofilox—TOP2A—Circadian rythm related genes—EZH2—pancreatic cancer	0.000231	0.00492	CbGpPWpGaD
Podofilox—Dermatitis—Docetaxel—pancreatic cancer	0.000231	0.00157	CcSEcCtD
Podofilox—TOP2A—Mitotic G1-G1/S phases—TYMS—pancreatic cancer	0.00023	0.0049	CbGpPWpGaD
Podofilox—Headache—Docetaxel—pancreatic cancer	0.00023	0.00157	CcSEcCtD
Podofilox—Oedema—Doxorubicin—pancreatic cancer	0.000229	0.00156	CcSEcCtD
Podofilox—TUBA4A—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.000228	0.00485	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—TNF—pancreatic cancer	0.000226	0.00482	CbGpPWpGaD
Podofilox—TOP2A—Idarubicin—Epirubicin—pancreatic cancer	0.000226	0.0269	CbGdCrCtD
Podofilox—TOP2A—Doxorubicin—Epirubicin—pancreatic cancer	0.000226	0.0269	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Epirubicin—pancreatic cancer	0.000226	0.0269	CbGdCrCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	0.000226	0.00481	CbGpPWpGaD
Podofilox—Insomnia—Epirubicin—pancreatic cancer	0.000224	0.00152	CcSEcCtD
Podofilox—Skin disorder—Doxorubicin—pancreatic cancer	0.000222	0.00151	CcSEcCtD
Podofilox—Paraesthesia—Epirubicin—pancreatic cancer	0.000222	0.00151	CcSEcCtD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	0.000222	0.00472	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.000218	0.00463	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.000216	0.0046	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000216	0.0046	CbGpPWpGaD
Podofilox—Pain—Epirubicin—pancreatic cancer	0.000211	0.00144	CcSEcCtD
Podofilox—TOP2A—Epirubicin—Doxorubicin—pancreatic cancer	0.000209	0.0249	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Doxorubicin—pancreatic cancer	0.000209	0.0249	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Doxorubicin—pancreatic cancer	0.000209	0.0249	CbGdCrCtD
Podofilox—TOP2A—Cell Cycle—RBBP8—pancreatic cancer	0.000209	0.00445	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—FOXM1—pancreatic cancer	0.000207	0.00441	CbGpPWpGaD
Podofilox—Insomnia—Doxorubicin—pancreatic cancer	0.000207	0.00141	CcSEcCtD
Podofilox—Paraesthesia—Doxorubicin—pancreatic cancer	0.000205	0.0014	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000203	0.00431	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—HIF1A—pancreatic cancer	0.000199	0.00423	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—GADD45A—pancreatic cancer	0.000197	0.0042	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—PLAU—pancreatic cancer	0.000197	0.00419	CbGpPWpGaD
Podofilox—Pain—Doxorubicin—pancreatic cancer	0.000196	0.00133	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	0.000191	0.00408	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	0.000189	0.00403	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000183	0.0039	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—NOTCH1—pancreatic cancer	0.000183	0.0039	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.000182	0.00387	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000177	0.00378	CbGpPWpGaD
Podofilox—TOP2A—Azacitidine—Gemcitabine—pancreatic cancer	0.000175	0.0208	CbGdCrCtD
Podofilox—Pruritus—Epirubicin—pancreatic cancer	0.000175	0.00119	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000174	0.00371	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000174	0.00371	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—CD44—pancreatic cancer	0.000173	0.00369	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	0.000168	0.00358	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IFNA1—pancreatic cancer	0.000168	0.00358	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TYMS—pancreatic cancer	0.000167	0.00356	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	0.000165	0.00351	CbGpPWpGaD
Podofilox—Dizziness—Epirubicin—pancreatic cancer	0.000163	0.00111	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—PPP2R5B—pancreatic cancer	0.000162	0.00346	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	0.000162	0.00345	CbGpPWpGaD
Podofilox—Pruritus—Doxorubicin—pancreatic cancer	0.000162	0.0011	CcSEcCtD
Podofilox—Vomiting—Epirubicin—pancreatic cancer	0.000157	0.00107	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—IFNA2—pancreatic cancer	0.000156	0.00333	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—RB1—pancreatic cancer	0.000156	0.00332	CbGpPWpGaD
Podofilox—Rash—Epirubicin—pancreatic cancer	0.000156	0.00106	CcSEcCtD
Podofilox—Dermatitis—Epirubicin—pancreatic cancer	0.000156	0.00106	CcSEcCtD
Podofilox—NR3C1—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000155	0.0033	CbGpPWpGaD
Podofilox—Headache—Epirubicin—pancreatic cancer	0.000155	0.00106	CcSEcCtD
Podofilox—Dizziness—Doxorubicin—pancreatic cancer	0.000151	0.00103	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	0.000147	0.00312	CbGpPWpGaD
Podofilox—Vomiting—Doxorubicin—pancreatic cancer	0.000145	0.000992	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—FOXM1—pancreatic cancer	0.000145	0.00308	CbGpPWpGaD
Podofilox—Rash—Doxorubicin—pancreatic cancer	0.000144	0.000983	CcSEcCtD
Podofilox—Dermatitis—Doxorubicin—pancreatic cancer	0.000144	0.000982	CcSEcCtD
Podofilox—Headache—Doxorubicin—pancreatic cancer	0.000143	0.000977	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—CDKN2A—pancreatic cancer	0.000142	0.00303	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—TYMS—pancreatic cancer	0.000142	0.00302	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	0.000137	0.00292	CbGpPWpGaD
Podofilox—NR3C1—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.000134	0.00286	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—BRCA2—pancreatic cancer	0.000133	0.00284	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000132	0.00281	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	0.000132	0.00281	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—GCG—pancreatic cancer	0.000131	0.00278	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CXCL8—pancreatic cancer	0.000129	0.00274	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TYMS—pancreatic cancer	0.000127	0.0027	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000126	0.00269	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000125	0.00266	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—CTNNB1—pancreatic cancer	0.000122	0.00259	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—HIF1A—pancreatic cancer	0.000121	0.00258	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—TYMS—pancreatic cancer	0.000121	0.00257	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CCND1—pancreatic cancer	0.00012	0.00256	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CTNNB1—pancreatic cancer	0.000119	0.00253	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—PPARG—pancreatic cancer	0.000118	0.00252	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	0.000117	0.0025	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MMP9—pancreatic cancer	0.000117	0.00248	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—PTEN—pancreatic cancer	0.000116	0.00247	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	0.000116	0.00247	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	0.000114	0.00244	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—pancreatic cancer	0.000114	0.00242	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—BRCA2—pancreatic cancer	0.000113	0.00241	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PLAU—pancreatic cancer	0.000111	0.00236	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TERT—pancreatic cancer	0.00011	0.00235	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	0.000108	0.00231	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TYMS—pancreatic cancer	0.000108	0.0023	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	0.000105	0.00224	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000105	0.00223	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—PPARG—pancreatic cancer	0.000103	0.00219	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	9.96e-05	0.00212	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CG—pancreatic cancer	9.86e-05	0.0021	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—RB1—pancreatic cancer	9.85e-05	0.0021	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—TGFB1—pancreatic cancer	9.83e-05	0.00209	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—EGF—pancreatic cancer	9.75e-05	0.00208	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	9.71e-05	0.00207	CbGpPWpGaD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	9.68e-05	0.00206	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MYC—pancreatic cancer	9.63e-05	0.00205	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—RB1—pancreatic cancer	9.61e-05	0.00205	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TGFB1—pancreatic cancer	9.6e-05	0.00205	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	9.57e-05	0.00204	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TERT—pancreatic cancer	9.39e-05	0.002	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—MYC—pancreatic cancer	9.29e-05	0.00198	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	9.01e-05	0.00192	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	8.94e-05	0.0019	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CHD3—pancreatic cancer	8.9e-05	0.0019	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MEN1—pancreatic cancer	8.9e-05	0.0019	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	8.77e-05	0.00187	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	8.69e-05	0.00185	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CD—pancreatic cancer	8.67e-05	0.00185	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—RB1—pancreatic cancer	8.6e-05	0.00183	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	8.57e-05	0.00182	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	8.47e-05	0.0018	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	8.45e-05	0.0018	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—TYMS—pancreatic cancer	8.43e-05	0.0018	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	8.43e-05	0.0018	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—RB1—pancreatic cancer	8.18e-05	0.00174	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—PTEN—pancreatic cancer	8.13e-05	0.00173	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—BRCA2—pancreatic cancer	7.93e-05	0.00169	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—pancreatic cancer	7.91e-05	0.00168	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	7.85e-05	0.00167	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	7.65e-05	0.00163	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN2A—pancreatic cancer	7.56e-05	0.00161	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CB—pancreatic cancer	7.56e-05	0.00161	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TYMS—pancreatic cancer	7.54e-05	0.00161	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NR5A2—pancreatic cancer	7.46e-05	0.00159	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—RB1—pancreatic cancer	7.31e-05	0.00156	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	7.3e-05	0.00156	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CTNNB1—pancreatic cancer	7.24e-05	0.00154	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	7.19e-05	0.00153	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	7.17e-05	0.00153	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND1—pancreatic cancer	7.14e-05	0.00152	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	7.04e-05	0.0015	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	7.02e-05	0.0015	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—pancreatic cancer	6.97e-05	0.00148	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	6.88e-05	0.00147	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP2—pancreatic cancer	6.87e-05	0.00146	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	6.79e-05	0.00145	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TERT—pancreatic cancer	6.57e-05	0.0014	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	6.55e-05	0.0014	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	6.5e-05	0.00138	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	6.49e-05	0.00138	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2A—pancreatic cancer	6.43e-05	0.00137	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCND1—pancreatic cancer	6.38e-05	0.00136	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—STAT3—pancreatic cancer	6.31e-05	0.00135	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	6.26e-05	0.00133	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND1—pancreatic cancer	6.07e-05	0.00129	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SRC—pancreatic cancer	6.06e-05	0.00129	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	5.97e-05	0.00127	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	5.94e-05	0.00127	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—pancreatic cancer	5.9e-05	0.00126	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	5.88e-05	0.00125	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TGFB1—pancreatic cancer	5.85e-05	0.00125	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NRAS—pancreatic cancer	5.83e-05	0.00124	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	5.78e-05	0.00123	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—pancreatic cancer	5.73e-05	0.00122	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—RB1—pancreatic cancer	5.72e-05	0.00122	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CXCL8—pancreatic cancer	5.71e-05	0.00122	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—pancreatic cancer	5.55e-05	0.00118	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	5.51e-05	0.00117	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—pancreatic cancer	5.46e-05	0.00116	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND1—pancreatic cancer	5.43e-05	0.00116	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TGFB1—pancreatic cancer	5.41e-05	0.00115	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	5.4e-05	0.00115	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CTNNB1—pancreatic cancer	5.27e-05	0.00112	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—pancreatic cancer	5.12e-05	0.00109	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—RB1—pancreatic cancer	5.11e-05	0.00109	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	5.03e-05	0.00107	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—KRAS—pancreatic cancer	5.01e-05	0.00107	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.88e-05	0.00104	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—pancreatic cancer	4.87e-05	0.00104	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	4.72e-05	0.00101	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CA—pancreatic cancer	4.61e-05	0.000981	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2A—pancreatic cancer	4.49e-05	0.000957	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—pancreatic cancer	4.46e-05	0.000949	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—pancreatic cancer	4.35e-05	0.000928	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MEN1—pancreatic cancer	4.28e-05	0.000912	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HRAS—pancreatic cancer	4.26e-05	0.000908	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—pancreatic cancer	4.25e-05	0.000905	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—pancreatic cancer	4.21e-05	0.000896	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	4.06e-05	0.000865	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	3.98e-05	0.000848	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	3.87e-05	0.000825	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—pancreatic cancer	3.8e-05	0.000809	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—pancreatic cancer	3.76e-05	0.000802	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	3.76e-05	0.0008	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—pancreatic cancer	3.58e-05	0.000762	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EZH2—pancreatic cancer	3.53e-05	0.000751	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	3.45e-05	0.000736	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—pancreatic cancer	3.41e-05	0.000726	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	3.27e-05	0.000697	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PRSS1—pancreatic cancer	3.19e-05	0.00068	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—pancreatic cancer	3.05e-05	0.000649	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ARG2—pancreatic cancer	2.77e-05	0.00059	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SMAD4—pancreatic cancer	2.6e-05	0.000554	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—pancreatic cancer	2.5e-05	0.000533	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TYMP—pancreatic cancer	2.42e-05	0.000515	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	2.14e-05	0.000456	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2e-05	0.000425	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.95e-05	0.000415	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.92e-05	0.000409	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.92e-05	0.000409	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	1.92e-05	0.000408	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.82e-05	0.000388	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPARG—pancreatic cancer	1.81e-05	0.000385	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.8e-05	0.000384	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.74e-05	0.00037	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.66e-05	0.000355	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.58e-05	0.000337	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.45e-05	0.00031	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CD44—pancreatic cancer	1.41e-05	0.0003	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.38e-05	0.000294	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.37e-05	0.000291	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GCG—pancreatic cancer	1.35e-05	0.000288	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—STK11—pancreatic cancer	1.27e-05	0.000271	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.19e-05	0.000254	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.17e-05	0.00025	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.15e-05	0.000246	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.09e-05	0.000233	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TYMS—pancreatic cancer	1.09e-05	0.000233	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—pancreatic cancer	1.03e-05	0.00022	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOE—pancreatic cancer	8.89e-06	0.000189	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CD44—pancreatic cancer	8.48e-06	0.000181	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.41e-06	0.000179	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GCG—pancreatic cancer	8.13e-06	0.000173	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	8.02e-06	0.000171	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARG—pancreatic cancer	7.74e-06	0.000165	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—STK11—pancreatic cancer	7.64e-06	0.000163	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—pancreatic cancer	7.15e-06	0.000152	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	7.05e-06	0.00015	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.57e-06	0.00014	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	6.15e-06	0.000131	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—pancreatic cancer	6.09e-06	0.00013	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOE—pancreatic cancer	5.35e-06	0.000114	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTEN—pancreatic cancer	5.31e-06	0.000113	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.82e-06	0.000103	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.66e-06	9.92e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.24e-06	9.03e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	3.75e-06	7.98e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.7e-06	7.87e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.66e-06	7.8e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.19e-06	6.8e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—pancreatic cancer	3.06e-06	6.52e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.25e-06	4.8e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.84e-06	3.92e-05	CbGpPWpGaD
